Ozlo, the maker of noise masking Sleepbuds designed to improve rest, is repositioning its product from a standalone device into a broader technology platform, as it seeks new growth avenues beyond consumer hardware. The shift gained momentum last month with a partnership with meditation app Calm and accelerated this week at the Consumer Electronics Show in Las Vegas, where the company held talks with potential partners across wellness, healthcare and software.
Founded by former Bose employees, Ozlo said the strategy is built around its software development kit, which allows third party apps to tap directly into the same system that powers its own mobile app. Through built in sensors that track body movement, respiration, light and temperature, Ozlo devices can determine when users are relaxed or asleep and share that data with partners such as Calm. This creates a feedback loop that helps content providers understand whether their sleep and meditation content is actually effective, rather than relying on guesswork or volume alone.
The company plans to monetize this ecosystem through subscriptions and partnerships, including premium features powered by artificial intelligence and targeted therapies such as tinnitus relief. Ozlo said about 15 percent of its users experience tinnitus and it plans to roll out subscription based therapy tools in the second quarter of 2026, following clinical studies conducted with Walter Reed Hospital. AI will also play a growing role inside Ozlo’s own app, with new features planned to help users better understand sleep patterns and interact with an AI powered sleep assistant.
Alongside software expansion, Ozlo is refreshing its hardware lineup and entering new markets. Updated Sleepbuds and a redesigned charging case are expected in the second quarter, alongside a new bedside speaker aimed at families and older users who prefer not to wear earbuds at night. The company has also acquired Irish neurotechnology firm Segotia to develop EEG enabled hearables, with medical grade products planned for 2027. As Ozlo pushes into healthcare and platforms, the Boston based company confirmed it is currently closing a Series B funding round to support its next phase of growth.